World Library  
Flag as Inappropriate
Email this Article

HIV superinfection

Article Id: WHEBN0008885590
Reproduction Date:

Title: HIV superinfection  
Author: World Heritage Encyclopedia
Language: English
Subject: Subtypes of HIV, HIV Drug Resistance Database, HIV-associated pruritus, HIV-affected community, HIV/AIDS in the United Arab Emirates
Collection: Hiv/Aids
Publisher: World Heritage Encyclopedia

HIV superinfection

HIV superinfection (also called HIV reinfection) is a condition in which a person with established human immunodeficiency virus infection acquires a second strain of the virus.[1] The second strain co-exists with the first and may cause more rapid disease progression or carry resistance to certain HIV medication.

People with HIV risk superinfection by the same actions that would place a non-infected person at risk of acquiring HIV. These include sharing needles and forgoing condoms with HIV-positive sexual partners. For many years superinfection was thought to occur mainly in high-risk populations. However, research from Uganda published in 2012 demonstrated that HIV superinfection occurs at a similar rate to the rate of primary HIV infection in a general heterosexual population.[2] In addition, preliminary results of female bar workers in Kenya presented at the 2012 Conference of Retroviruses and Opportunistic Infections by researchers at the Fred Hutchinson Cancer Research Center also found that HIV superinfection occurs at a similar rate to primary HIV infection.

Immunology of HIV superinfection

It is unknown what aspects of the natural immune response to HIV may protect someone from superinfection, but it has been shown that cytotoxic lymphocyte responses do not seem to be protective.[3] In addition, it has been demonstrated that superinfection can occur in individuals that demonstrate a robust anti-HIV antibody response. Interestingly, the anti-HIV antibody response broadens and strengthens in individuals post-superinfection.[4] Taken with the finding that super-infection is common and occurs within and between HIV subtypes it has been suggested that the immune response elicited by primary infection may confer limited protection and raises concerns that HIV-vaccine strategies designed to replicate the natural anti-HIV immune response may have limited effectiveness in preventing new infections. However at the same time, HIV-infected individuals at high-risk for super-infection who do not become superinfected may also provide a very interesting avenue for new vaccine research.

HIV co-infection offset

A study in the New England Journal of Medicine titled 'Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection' revealed that people who are HIV+ with the two major subtypes actually have a slower progression towards AIDS than people with only HIV-1 or HIV-2. This challenges the notion of Superinfection by illustrating that contemporaneous infection can actually offset itself.[5]


  1. ^ Smith DM, Richman DD, Little SJ (August 2005). "HIV superinfection". J. Infect. Dis. 192 (3): 438–44.  
  2. ^ Redd, Andrew; et al (June 2012). "The Rates of HIV Superinfection and Primary HIV Incidence in a General Population in Rakai,  
  3. ^ Blish, Catherine; et al (2011). "Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study". AIDS 26 (5): 643–6.  
  4. ^ Cortez, Valerie; et al (2012). "HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response". PLOS Pathogens 8 (3): e1002611.  
  5. ^ Esbjörnsson, Joakim; et al (2012). "Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection". New England J. Med. 367 (3): 224–32.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.